Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Goat placenta extract in a special delivery system improved hair growth and thickness in chemotherapy patients.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Xiaoaiping reduces chemotherapy side effects and improves quality of life for breast cancer patients.

Hedgehog pathway inhibitors could be effective in treating melanoma.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Mast cells and VEGF contribute to post-surgery adhesions, and blocking VEGF can reduce these adhesions; also, certain factors affect wound healing and fetal skin heals differently with age.

Presurgical models can effectively and affordably screen cancer prevention agents.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Virtual reality can reduce pain during scalp injections.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

A special gel with medicine helps prevent melanoma from coming back after surgery.

Kang'ai injection with FLO chemotherapy improves effectiveness and quality of life in advanced gastric cancer patients.

Valproic acid is a more effective treatment for vomiting in Alexander disease than other medications, with few side effects.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Erenumab significantly reduced migraine days or severity in most patients after 3 months.